Labshake search
Citations for Tocris :
1 - 50 of 904 citations for Somatostatin Receptor 1 SSTR1 Mouse Monoclonal biotin labeled since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2024Quote: ... BIBP-3226 (Y1 receptor antagonist, 1-2 μM), and BIIE-0246 (Y2 receptor antagonist, 1-2 μM) were obtained from Tocris.
-
bioRxiv - Developmental Biology 2021Quote: ... the BMP type-I receptor inhibitor DMH-1 (1 μM, Tocris) and ROCK inhibitor Y-27632 2HCl (10 μM) ...
-
bioRxiv - Cancer Biology 2022Quote: ... the BMP type-I receptor inhibitor DMH-1 (1 μM, Tocris) and ROCK inhibitor Y-27632 2HCl (10 μM) ...
-
bioRxiv - Cancer Biology 2022Quote: ... the BMP type-I receptor inhibitor DMH-1 (1 μM, Cat# 4126, Tocris), 10 μM of Rock Inhibitor (Y-27632 ...
-
bioRxiv - Neuroscience 2021Quote: ... To interfere with group I metabotropic glutamate receptor (mGluR) signaling we used bath application of either the mGlu1 receptor antagonist YM298198 (1 μM, Tocris, Germany) or the mGluR5 receptor antagonist MPEP (10 μM ...
-
bioRxiv - Cell Biology 2021Quote: Receptors were stimulated as follows: human Angiotensin 1 receptor (AT1R) with Angiotensin II (AngII; Tocris 4474-91-3, in measuring buffer), human β2 adrenergic receptor (β2ADR ...
-
bioRxiv - Neuroscience 2019Quote: ... glycine receptors (GlyR) and GABAB receptors 10 μM (−)Bicuculline methiodide (Tocris Bioscience), 2 μM Strychnine hydrochloride (Tocris Bioscience ...
-
bioRxiv - Biochemistry 2023Quote: ... 500 nM A83-01 TGF-ß type 1 receptor inhibitor (Tocris) and 10 µM SB202190 P38 MAPK inhibitor (Sigma-Aldrich) ...
-
bioRxiv - Cell Biology 2022Quote: Taxol microtubules were prepared as described above, however were labeled with 16% biotin and 5% Alexa555 tubulin and stored in BRB80T (BRB80, 10 μM Taxol (Tocris)) ...
-
bioRxiv - Neuroscience 2020Quote: ... and the NMDA receptor open-channel blocker MK-801 (Tocris, 1 mM) in the recording pipette solution ...
-
bioRxiv - Cell Biology 2021Quote: ... interleukin-1 receptor-associated kinase 1 and 4 (IRAK 1/4; IRAK 1/4 inhibitor, 0.1 μM; Tocris); TANK-binding kinase 1 (TBK1 ...
-
bioRxiv - Cell Biology 2020Quote: ... or blockers of receptors associated with OxPC activity including platelet activating factor receptor (WEB-2086, Tocris 2339), prostaglandin EP2 receptor (PF-04418948 ...
-
bioRxiv - Cell Biology 2020Quote: ... prostaglandin EP2 receptor (PF-04418948, Tocris 4814), CD36 [sulfosuccinimidyl oleate (SSO) ...
-
bioRxiv - Immunology 2019Quote: ... Adenosine receptor drugs were purchased from Tocris or Sigma Aldrich ...
-
bioRxiv - Immunology 2021Quote: ... and AT1 receptor antagonist Candesartan cilexetil (Tocris) were used in this study ...
-
bioRxiv - Immunology 2022Quote: ... the CCR3 receptor antagonist SB328437 (Tocris Bioscience) was added at a final concentration of 10 μM (41) ...
-
bioRxiv - Neuroscience 2023Quote: ... GABAB receptor antagonist CGP55845 (3 μM, Tocris), Na+ channel blocker tetrodotoxin (TTX ...
-
bioRxiv - Biochemistry 2023Quote: ... SKF81297 hydrobromide (D1-like receptor agonist, TOCRIS), quinpirole hydrochloride (D2-like receptor agonist ...
-
bioRxiv - Biochemistry 2023Quote: ... SCH 39166 (D1-like receptor antagonist, TOCRIS), raclopride (D2-like receptor antagonist ...
-
bioRxiv - Biochemistry 2023Quote: ... quinpirole hydrochloride (D2-like receptor agonist, TOCRIS), SCH 39166 (D1-like receptor antagonist ...
-
bioRxiv - Neuroscience 2019Quote: ... The receptor-selective agonists we used included SKF 81297 for D1-like receptors (10–50 µM; Tocris, Minneapolis, MN); quinpirole for D2-like receptors (10–50 µM ...
-
bioRxiv - Neuroscience 2022Quote: ... the AMPA/NMDA receptor agonist kynurenic acid (2 mM) and the GABA-A receptor antagonist picrotoxin (PTX; 100 uM, Tocris) were present ...
-
bioRxiv - Neuroscience 2020Quote: ... N-methyl D-aspartate (NMDA) receptors were blocked by the non-competitive NMDA receptor antagonist MK-801 (Tocris; 100 μM), co-applied with the competitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AMPA/kainate receptor antagonist CNQX (Tocris ...
-
bioRxiv - Developmental Biology 2020Quote: ... and TGFβ Receptor I Inhibitor II (25nM; Tocris were also used in this study ...
-
bioRxiv - Neuroscience 2020Quote: ... NMDA receptor blockers (D-AP5 50 μM, Tocris; (+)MK-801 10 μM ...
-
bioRxiv - Neuroscience 2021Quote: The Cck1 receptor (Cck1R) agonist A71623 (Tocris Biosciences) was suspended in 20mM PBS according to the manufacturer’s directions ...
-
bioRxiv - Neuroscience 2022Quote: ... the AMPA receptor blocker DNQX (10 mM, Tocris) was applied to the cortical surface in a subset of experiments ...
-
bioRxiv - Neuroscience 2023Quote: The general dopamine receptor antagonist flupenthixol dihydrochloride (Tocris) was prepared at a concentration of 100 μM in sterile 0.9% saline and frozen in aliquots that were thawed fresh immediately prior to use ...
-
bioRxiv - Neuroscience 2023Quote: ... and 50 μM NMDA receptor antagonist AP5 (Tocris). Data were filtered at 4 kHz and digitized at 20 kHz using Digidata 1550B and Clampex software (Molecular Devices) ...
-
bioRxiv - Neuroscience 2023Quote: ... AMPA receptor antagonist NBQX (20 μM, Tocris, 0373) and NMDA receptor antagonist APV (50 μM ...
-
bioRxiv - Immunology 2023Quote: ... AP-5 (25 nM, NMDA receptor blocker, Tocris), and actinomycin D (RNA polymerase inhibitor ...
-
bioRxiv - Neuroscience 2023Quote: ... The dopamine D2-receptor antagonist raclopride (Tocris Bioscience) was used at a concentration of 100 μM ...
-
bioRxiv - Neuroscience 2023Quote: ... CNQX (10 μM, Tocris; an AMPA receptor antagonist), glycine (10 μM ...
-
bioRxiv - Neuroscience 2024Quote: Oxytocin receptor antagonist (OTRA; L-368,899; Tocris 2641) was dissolved in saline 95% and DMSO 5% ...
-
bioRxiv - Neuroscience 2020Quote: ... Substance P was manipulated by injecting the agonist of the NK-1 receptor Substance P (Tocris) to an estimated final concentration of 200 nM ...
-
bioRxiv - Neuroscience 2021Quote: ... 3-((±)2-carboxypiperazin-4yl) propyl-1-phosphate (CPP, NMDA receptor antagonist, 20 μM; Tocris Bioscience, UK) and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX ...
-
bioRxiv - Biophysics 2021Quote: ... Chromatin was labeled with 1:1000 Hoechst solution (Tocris, Cat#5117). We mounted samples using 90% Glycerol (Sigma ...
-
bioRxiv - Cell Biology 2023Quote: ... Chromatin was labeled with 1:1000 Hoechst solution (Tocris, Cat# 5117), added to the 90% Glycerol (Sigma ...
-
bioRxiv - Cancer Biology 2020Quote: ... TGF-ß type I receptor inhibitor A83-01 (Tocris), P38 inhibitor SB202190 (Sigma-Aldrich) ...
-
bioRxiv - Neuroscience 2021Quote: ... the NMDA receptor blocker D-AP5 (25 μM; Tocris), and the GABAA receptor blocker picrotoxin (50 μM ...
-
bioRxiv - Neuroscience 2021Quote: ... and the GABAA receptor blocker picrotoxin (50 μM; Tocris).
-
bioRxiv - Neuroscience 2021Quote: ... glutamate and GABA receptor blockers (10 μM NBQX, Tocris, UK ...
-
bioRxiv - Neuroscience 2019Quote: ... the AMPA/kainate receptor antagonist 50μM NBQX (Tocris Bioscience) (Chandler et al. ...
-
bioRxiv - Neuroscience 2021Quote: ... 10 µM SR95531 (a blocker for GABAA receptors; Tocris) was used to verify the GABAergic nature of the currents recorded (data not shown) ...
-
bioRxiv - Neuroscience 2021Quote: ... the TrkB receptor antagonist ANA-12 (10 µM, Tocris), PKA inhibitor H89 (10 µM ...
-
Serotonin Modulates an Inhibitory Input to the Central Amygdala from the Ventral Periaqueductal GraybioRxiv - Neuroscience 2022Quote: ... 5HT2C receptor antagonist RS102221 (5 µM, Tocris, Minneapolis, MN) was added in the bath ...
-
bioRxiv - Neuroscience 2019Quote: ... quinpirole for D2-like receptors (10–50 µM; Tocris); and the D1/D2 receptor co-agonist SKF 83959 (10–50 µM ...
-
bioRxiv - Neuroscience 2022Quote: ... AP5 + CNQX cocktail (NMDA and AMPA receptor antagonists; Tocris) or aCSF as vehicle control ...
-
bioRxiv - Cancer Biology 2022Quote: ... TGF-ß type I receptor inhibitor A83-01 (Tocris), P38 inhibitor SB202190 (Sigma-Aldrich) ...
-
bioRxiv - Neuroscience 2022Quote: ... adrenergic α1A receptor antagonist – RS17053 (40 μM, Tocris 0985); adrenergic α1B receptor antagonist – Chloroethylclonidine (30 μM ...